Skip to main content
. Author manuscript; available in PMC: 2009 Mar 20.
Published in final edited form as: J Neurooncol. 2008 Jan 30;88(1):43–50. doi: 10.1007/s11060-008-9530-8

Table 1.

Baseline clinical characteristics.

Characteristic Group 1 Adjuvant TMZ only N=21 Group 2 Concurrent & adjuvant TMZ N=22 P value
Age (mean, SE) 57.8 (2.4) 55.5 (2.6) 0.65291

Gender
Male 11 (52%) 15 (68%) 0.35802
Female 10 (48%) 7 (32%)

KPS
<70 9 (43%) 4 (18%) 0.10402
≥70 12 (57%) 18 (82%)

Able to work
Yes 17 (81%) 15 (68%) 0.48762

No 4 (19%) 7 (32%)

RPA class
3 2 (9%) 4 (18%)
4 8 (38%) 9 (41%) 0.61702
5 6 (29%) 7 (32%)
6 5 (24%) 2 (9%)
1

P value derived from t-test.

2

P value derived from Fisher's exact test.